Compare Amphastar Pharmaceuticals Inc (AMPH) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while T-Rex 2X Long MSTR Daily Target ETF trades at $1.81. The key difference: Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| AMPH | MSTU | |
|---|---|---|
Market Cap | $826.08M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $30.81 | $106.80 |
52-Week Low | $16.87 | $1.46 |
Enterprise Value | $1.22B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
MSTU trades at $1.875, up 1.35% today, but the technical outlook is bearish with moving averages signaling strong selling pressure. The ETF, which aims for 2x daily returns of MicroStrategy (MSTR), has experienced extreme volatility and significant losses historically. Recent news highlights its high-risk nature, with articles noting substantial declines over the past year.
The outlook remains highly speculative due to leveraged exposure to MSTR's volatility. Key risks include daily rebalancing effects amplifying losses, dependence on MSTR's performance, and overall market sentiment toward Bitcoin-linked assets. This ETF is suitable only for investors comfortable with extreme risk and short-term trading.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
